(292 days)
Not Found
No
The document describes a standard multi-parameter patient monitor and does not mention any AI or ML capabilities in its description, intended use, or performance studies.
No
The device is described as a "monitor" that is used for "monitoring, storing, reviewing, recording, and generating alarms for multiple physiological parameters." It does not mention any therapeutic function or intervention.
Yes
The device is described as a "Patient Monitor" intended for "monitoring, storing, reviewing, recording, and generating alarms for multiple physiological parameters." While patient monitors gather data, they are not typically considered "diagnostic devices" as they do not interpret the data to provide a diagnosis of a condition. Diagnostic devices usually analyze data to identify diseases or conditions. This device simply presents physiological parameters and alarms for out-of-range values, leaving the interpretation and diagnosis to a healthcare professional.
No
The device description explicitly mentions hardware components such as a 17-inch touch screen, built-in Lithium-ion battery, and parameter modules (Sp02, NIBP, TEMP, etc.) which are integral to its function. The performance studies also include hardware testing.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the body (like blood, urine, tissue). This device monitors physiological parameters directly from the patient's body (ECG, SpO2, NIBP, etc.).
- The intended use and device description clearly state it's a patient monitor. It measures and displays vital signs and other physiological data in real-time.
- There is no mention of analyzing biological samples.
Therefore, this device falls under the category of a patient monitoring device, not an IVD.
N/A
Intended Use / Indications for Use
This monitor is intended to be used for monitoring, storing, reviewing, recording, and generating alarms for multiple physiological parameters including ECG, respiration (RESP), temperature (TEMP), functional arterial arterial oxygen saturation (Sp02), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure (IBP), expired C02, cardiac output (C.O.) and anesthetic gas (AG)of adults, pediatrics and neonates in hospital environments. The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.
This monitor is suitable for use in hospital environments including but not limited to OR, PACU, ICU and neonate intensive care room.
Product codes
MHX, DRT, DXN, DSK, FLL, DQA, CCK, CBQ, CBS, CBR, CCL, DSA, DRT, DSI, MLD
Device Description
The PM-2000M Patient Monitor can perform long-time continuous monitoring of multiple physiological parameters. Also, it is capable of storing, displaying, analyzing and controlling measurements, and it will indicate alarms in case of abnormities happen.
The PM-2000M realizes the monitoring of physiological parameters by configuration with different parameter modules which include Sp02 (pulse oxygen saturation, pulse rate and Sp02 plethysmogram) with EDAN Sp02 module or Nellcor SP02 module, NIBP (systolic pressure, diastolic pressure, mean pressure and pulse rate), TEMP, ECG, RESP, C02, IBP, C.O. and AG.
The above is the maximum configuration for elite VB, the user may select different monitoring parameters in according with the requirement.
The PM-2000M is configured with a 17-inch touch screen and build-in Lithium-ion battery, Besides, and supports software upgrade online and networking
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adults, pediatrics and neonates
Intended User / Care Setting
hospital environments including but not limited to OR, PACU, ICU and neonate intensive care room.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The following quality assurance measures were applied to the development of the Patient Monitor
Software testing
Hardware testing
Safety testing
Environment testing
Risk analysis
Final validation
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 23, 2014
Advanced Instrumentations, Inc. Jorge Millan 601 West 20th Street Hialeah, FL 33010 US
| Re: | K132077 |
|---|---|
| Trade/Device Name: | PM-2000M Patient monitor |
| Regulation Number: | 21 CFR 870.1025 |
| Regulation Name: | Patient Physiological Monitor (With Arrhythmia Detection or |
| Alarms) | |
| Regulatory Class: | Class II |
| Product Code: | MHX, DRT, DXN, DSK, FLL, DQA, CCK, CBQ, CBS, CBR, |
| CCL, DSA, DRT, DSI, MLD | |
| Dated: | March 26, 2014 |
| Received: | March 28, 2014 |
Dear Jorge Millan,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mitchell Stein
forBram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known): K132077
Device Name:
PM-2000M Patient Monitor
Indications for Use:
This monitor is intended to be used for monitoring, storing, reviewing, recording, and generating alarms for multiple physiological parameters including ECG, respiration (RESP), temperature (TEMP), functional arterial oxygen saturation (Sp02), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure (IBP), expired C02, cardiac output (C.O.) and anesthetic gas (AG)of adults, pediatrics and neonates in hospital environments. The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.
This monitor is suitable for use in hospital environments including but not limited to OR, PACU, ICU and neonate intensive care room.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Date: 2014.04.23
08:55:00 -04'00'
Page 1 of
3
510(k) Summary of Safety and Effectiveness
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92.
The assigned 510(k) number is: K132077
Submitter
Advanced Instrumentations, Inc. 6800 N.W. 77th Court Miami, Fl 33166 Telephone: 305-477-6331 Fax: 305-477-5351
Registration # 1066270
Official correspondent :
Jorge Millan, PhD Email: jmillan@hiatec.org 601 West 20 St Hialeah, FL 33010 Phone : (305) 925-1260
Date Prepared:
March 26, 2014
Device name and classification:
- Device Name: PM-2000M Patient Monitor ●
- Common Name: Patient Monitor Arrhythmia detector and alarm ●
4
. Classification
| Description | Classification | Product
Code |
|------------------------------------------------------------------------------------------|----------------|-----------------|
| 21 CFR 870.1025 monitor, physiological, patient (with
arrhythmia detection or alarms) | II | MHX |
| 21 CR 870.2300 Cardiac monitor (including cardiotachoment
and rate alarm) | II | DRT |
| 21 CFR 870.1130 Non-Invasive blood pressure measurement | II | DXN |
| 21 CFR 870.1110 Blood pressure computer | II | DSK |
| 21 CFR 880.2910 Clinical Electronic Thermometers-
Temperature Monitor with Probe | II | FLL |
| 21 CFR 870.2700 Oximeter, Pulse | II | DQA |
| 21 CFR 868.1400 Carbon Dioxide Gas Analyzer | II | CCK |
| 21 CFR 868.1500 Enflurane gas analyzer | II | CBQ |
| 21 CFR 868.1620 Halothane gas analyzer | II | CBS |
| 21 CFR 868.1700 Nitrous Oxide gas analyzer | II | CBR |
| 21 CFR 868.1720 Oxygen gas analyzer | II | CCL |
| 21 CFR 870.2900 cable, transducer and electrode,
patient, (including connector) | II | DSA |
| 21 CFR 870.2300 monitor, cardiac (incl. cardiotachometer &
rate alarm) | II | DRT |
| 21 CFR 870.1025 Detector and Alarm, Arrhythmia | II | DSI |
| 21 CFR 870.1025 Monitor, ST Segment with Alarm | II | MLD |
Regulatory Class: Class II .
Predicate Device:
V8 Patient Monitor, K120173 Manufacturer: EDAN Instruments
Device Description:
The PM-2000M Patient Monitor can perform long-time continuous monitoring of multiple physiological parameters. Also, it is capable of storing, displaying, analyzing and controlling measurements, and it will indicate alarms in case of abnormities happen.
The PM-2000M realizes the monitoring of physiological parameters by configuration with different parameter modules which include Sp02 (pulse oxygen saturation, pulse rate and Sp02 plethysmogram) with EDAN Sp02 module or Nellcor SP02 module, NIBP (systolic pressure, diastolic pressure, mean pressure and pulse rate), TEMP, ECG, RESP, C02, IBP, C.O. and AG.
5
The above is the maximum configuration for elite VB, the user may select different monitoring parameters in according with the requirement.
The PM-2000M is configured with a 17-inch touch screen and build-in Lithium-ion battery, Besides, and supports software upgrade online and networking
Comparison to the predicate device:
The subject device has same technology characteristics, materials, design, manufacturing processes, operating principle, performance specifications and has the same indications for use as the predicate device.
Intended Use:
This monitor is intended to be used for monitoring, storing, reviewing, recording, and generating alarms for multiple physiological parameters including ECG, respiration (RESP), temperature (TEMP), functional arterial oxygen saturation (Sp02), pulse rate (PR), non-invasive blood pressure (NIBP), invasive blood pressure (IBP), expired C02, cardiac output (C.O.) and anesthetic gas (AG)of adults, pediatrics and neonates in hospital environments. The monitor is equipped with alarms that indicate system faults (such as loose or defective electrodes), physiologic parameters that have exceeded the limits set by the operator, or both.
This monitor is suitable for use in hospital environments including but not limited to OR, PACU, ICU and neonate intensive care room.
Contraindications
It is not intended for use in patient's home or residence, or when it has not been ordered by a physician.
Effectiveness and Safety Contraindications:
Test Summary
The following quality assurance measures were applied to the development of the Patient Monitor
Software testing Hardware testing Safety testing
6
Environment testing Risk analysis Final validation
Substantially Equivalent Determination:
This premarket notification submission demonstrates that PM-2000M Patient Monitor is substantially equivalent to the predicate device.